ID

23891

Beschrijving

Study part: Adverse Events- Post- Vaccination Observation Booster Dose. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Trefwoorden

Versies (1)
  1. 16-07-17 16-07-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

16 juli 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Adverse Events- Post- Vaccination Observation Booster Dose Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

Engels

Adverse Events- Post- Vaccination Observation Booster Dose

1 Formulieren  
ADVERSE EVENTS – POST–VACCINATION OBSERVATION
Beschrijving

ADVERSE EVENTS – POST–VACCINATION OBSERVATION

Alias
UMLS CUI-1
C0877248
Subject number
Beschrijving

Subject number

Datatype

integer

Alias
UMLS CUI [1]
C2348585
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
Beschrijving

Adverse Events

Datatype

text

Alias
UMLS CUI [1]
C0877248
Terug naar het begin van de pagina

Similar models

Adverse Events- Post- Vaccination Observation Booster Dose

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
ADVERSE EVENTS – POST–VACCINATION OBSERVATION
C0877248 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Item
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
text
C0877248 (UMLS CUI [1])
Adverse Events
Code List
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
CL Item
Information not retrievable [U (Information not retrievable [U)
CL Item
No Vaccine administered [NA (No Vaccine administered [NA)
CL Item
No [N (No [N)
CL Item
Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y (Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y)
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial